For those with hypermobility and EDS specifically, Id flag the following as the minimum due diligence before starting these medications: A thorough GI history and ideally gastric emptying assessment if theres any existing dysmotility Baseline muscle mass measurement (DEXA or similar) given the sarcopenia risk A clear plan for high-protein diet and resistance-based exercise to mitigate muscle loss Baseline bone density if theres any existing concern Consideration of the nutritional picture specific to hypermobility, since these drugs can affect appetite and nutrient absorption A conversation specifically about MCAS if thats a feature of your presentation The medication options for hypermobility and EDS are limited and often unsatisfying, and its entirely understandable why people are looking at something new with genuine curiosity
About Omada Health: Omada Health (Nasdaq: OMDA) is reverse engineering the way healthcare is delivered in America, putting the space between doctor visitswhere health is won or lostat the center of care
This could be because vitamin C influences the production of L-carnitine, an amino acid that helps your body burn fat for energy
If you want to explore this area further, HubMed Ed offers online aesthetic courses for doctors you can take at your convenience and improve your expertise
Colvin OM, Friedman HS, Gamcsik MP, Fenselau C, Hilton J
Whether this is because of the limit of detection of the neuroprotection assays, or because the semaglutide-induced neuroprotective effects were already maximal, needs to be investigated further
